TrialGynecologic oncology2019

An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.

Martin Gore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.